Skip to main content

Surrozen, Inc./DE

For the period ended Jun 30, 2025. Filed Aug 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 8, 2025

SRZN$32.64+2.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Unaudited Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

Three Months Ended · Six Months Ended
June 30,June 30,
2025202420252024
Research service revenue – related party$983$—$1,966$—
Operating expenses:
Research and development6,0425,33512,60010,582
General and administrative3,9583,7147,9347,597
Total operating expenses10,0009,04920,53418,179
Loss from operations(9,017)(9,049)(18,568)(18,179)
Interest income1,0254901,321875
Loss on issuance of common stock, pre-funded warrants and warrants in the 2024 PIPE—(20,397)—(20,397)
Loss on amendment and cancellation of warrants——(2,073)—
Loss on execution of the 2025 PIPE——(71,084)—
Gain on change in fair value of tranche liability31,520—47,860—
Gain on settlement of tranche liability——1,117—
Other income, net (Note 3)16,2183,69554,2033,610
Net income (loss)$39,746$(25,261)$12,776$(34,091)
Net income (loss) available to (attributable to) common stockholders, basic and diluted$21,808$(25,261)$5,210$(34,091)
Net income (loss) per share available to (attributable to) common stockholders, basic and diluted$2.55$(7.99)$0.85$(13.00)
Weighted-average shares used in computing net income (loss) per share available to (attributable to) common stockholders, basic and diluted8,5413,1626,0982,622

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(In thousands)

Additional · Total
Common stock · paid-in · Accumulated · stockholders’
SharesAmountcapitaldeficitequity
Balance at December 31, 20243,262$—$263,879$(285,259)$(21,380)
Issuance of common stock in the 2025 PIPE5,213153,189—53,190
Vesting of restricted stock units20————
Stock-based compensation expense——834—834
Net loss———(26,970)(26,970)
Balance at March 31, 20258,4951317,902(312,229)5,674
Issuance of common stock under employee stock purchase plan7—61—61
Issuance of common stock upon warrant exercise68—677—677
Issuance costs for the 2025 PIPE——(38)—(38)
Stock-based compensation expense——994—994
Net income———39,74639,746
Balance at June 30, 20258,570$1$319,596$(272,483)$47,114
Additional · Total
Common stock · paid-in · Accumulated · stockholders’
SharesAmountcapitaldeficitequity
Balance at December 31, 20232,063$—$259,630$(221,695)$37,935
Vesting of restricted stock units44————
Vesting of early exercised stock options——1—1
Stock-based compensation expense——1,030—1,030
Net loss———(8,830)(8,830)
Balance at March 31, 20242,107—260,661(230,525)30,136
Issuance of common stock in the 2024 PIPE1,092————
Issuance of common stock under employee stock purchase plan7—42—42
Stock-based compensation expense——1,145—1,145
Net loss———(25,261)(25,261)
Balance at June 30, 20243,206$—$261,848$(255,786)$6,062
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.